Clinical Trials Search at Vanderbilt-Ingram Cancer Center

APOLLO-B - A Phase 3, Randomized, Double-blind, Placebo-controlled Multicenter Study to Evaluate the Efficacy and Safety of Patisiran in Patients with Transthyretin Amyloidosis with Cardiomyopathy (ATTR Amyloidosis with Cardiomyopathy)

Disease Sites:

Not Available

Staging:

Phase II/III

Age Group:

Adults

Therapies:

Not Available

Drugs:

Not Available

Principal Investigator(s):

Hung, Rebecca

Participating Institutions:

Vanderbilt University

Open Date:

11-19-2019

Trial Type:

Other

Protocol ID:

CRE-CHF0004

Related Internal Documents:

View Internal Documents

Eligibility

Ages Eligible for Study:

Not Available

Genders Eligible for Study:

Not Available

Accepts Healthy Volunteers?:

Not Available